Method for assaying compounds or agents for ability to decrease the activity of microsomal prostaglandin E synthase or hematopoietic prostaglandin D synthase
AssigneeAventis Pharmaceuticals Inc.
InventorsZhuyin Li, Junjie Xiong, Henry Ma, Jeffrey S. Sabol
Life of this patent
Estimating the term…
Abstract
Provided herein is a novel and useful method for evaluating the ability of compounds or agents to decrease the activity of microsomal prostaglandin E synthase or hematopoietic prostaglandin D synthase to produce their respective prostaglandin products.
Claims28
A method for determining whether a compound or agent decreases the activity of a prostaglandin synthase selected from the group consisting of a microsomal prostaglandin E synthase (MPGES) and a hematopoietic prostaglandin D synthase (hPGDS) to react with a substrate to form a prostaglandin product, comprising the steps of:
- (a) mixing the prostaglandin synthase with the substrate, a cofactor and the compound or agent;
- (b) incubating the mixture of step (a) with a stop solution comprising an agent that prevents the spontaneous conversion of the substrate into the prostaglandin product;
- (c) incubating the mixture of step (b) with a detection reagent comprising the prostaglandin product labeled with a fluorescence label, and an antibody having the prostaglandin product as an immunogen;
- (d) illuminating the mixture of step (c) and a control mixture with plane polarized light having a wavelength at which the fluorescence label can be excited, and measuring the fluorescence polarization of the mixture of step (c) and the control mixture;
- and
- (e) comparing the measurements of step (d),
- wherein finding the fluorescence polarization measurement of the mixture (c) is greater than the fluorescence polarization measurement of control mixture indicates the compound or agent decreases the activity of the prostaglandin synthase.
A method for determining whether a compound or agent decreases the activity of a prostaglandin synthase selected from the group consisting of hematopoietic prostaglandin D synthase (hPGDS) and microsomal prostaglandin E synthase (mPGES) to react with a substrate to form a prostaglandin product, comprising the steps of:
- (a) mixing the prostaglandin synthase with the substrate, a cofactor and the compound or agent;
- (b) incubating the mixture of step (a) with a stop solution comprising an agent that prevents spontaneous conversion of unreacted substrate into prostaglandin product;
- (c) incubating the mixture of step (b) with a detection reagent comprising the prostaglandin product labeled with Texas Red, and an antibody having the prostaglandin product as an immunogen;
- (d) illuminating the mixture of step (c) and a control mixture with plane polarized light at a wavelength of 580±20 nm and measuring the fluorescence polarization of the mixture of step (c) and the control mixture at 620±20 nm;
- and
- (e) comparing the measurements of step (d),
- wherein finding the fluorescence polarization measurement of the mixture of step (c) is greater than the fluorescence polarization measurement of control mixture indicates the compound or agent decreases the activity of the prostaglandin synthase.
A method for determining whether a compound or agent decreases the activity of human microsomal prostaglandin E synthase (mPGES) comprising the amino acid sequence of SEQ ID NO:2 to react with its prostaglandin H2 (PGH2) substrate to form prostaglandin E2 (PGE2), the method comprising the steps of:
- (a) mixing the mPGES with PGH2, glutathione, and the compound or agent;
- (b) incubating the mixture of step (a) with a stop solution comprising FeCl2;
- (c) incubating the mixture of step (b) with a detection reagent comprising PGE2 labeled with Texas Red, and an antibody having PGE2 as an immunogen;
- (d) illuminating the mixture of step (c) and a control mixture with plane polarized light at a wavelength of 580±20 nm and measuring the fluorescence polarization of the mixture of step (c) and the control mixture;
- and
- (e) comparing the measurements of step (d),
- wherein finding the fluorescence polarization measurement of the mixture of step (c) is greater than the fluorescence polarization measurement of the control mixture indicates the compound or agent decreases the activity of the mPGES.
A method for determining whether a compound or agent decreases the activity of human hematopoietic prostaglandin D synthase (hPGDS) comprising the amino acid sequence of SEQ ID NO:4 to react with its prostaglandin H2 (PGH2) substrate to form prostaglandin D2 (PGD2), comprising the steps of:
- (a) mixing hPGDS with PGH2, glutathione and the compound or agent;
- (b) incubating the mixture of step (a) with a stop solution comprising FeCl2;
- (c) incubating the mixture of step (b) with a detection reagent comprising PGD2 labeled with Texas Red, and an antibody having PGD2 as an immunogen;
- (d) illuminating the mixture of step (c) and a control mixture with plane polarized light at a wavelength of 580±20 nm and measuring the fluorescence polarization of the mixture of step (c) and the control mixture;
- and
- (e) comparing the measurements of step (d),
- wherein finding the fluorescence polarization measurement of the mixture of step (c) is greater than the fluorescence polarization measurement of control mixture indicates the compound or agent decreases the activity of hPGDS.
Dependencies are inferred from the claim text.